Intrinsic Value of S&P & Nasdaq Contact Us

PolyPid Ltd. PYPD NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • IL • USD

SharesGrow Score
56/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$9.50
+114.9%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

PolyPid Ltd. (PYPD) has a negative trailing P/E of -2.6, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 21.1 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -38.78%, forward earnings yield 4.75%. PEG 0.06 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (100/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.06); analyst target implies upside (+114.9%).
  • Forward P/E 21.1 — analysts expect a return to profitability with estimated EPS of $0.21 for FY2028.
  • PEG Ratio 0.06 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -38.78% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 4.75% as earnings recover.
  • Analyst consensus target $9.50 (+114.9% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 54/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
56/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
94/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
MOAT
28/100
→ Income
~
GROWTH
45/100
→ Income
INCOME
N/A
No coverage

Valuation Snapshot — PYPD

Valuation Multiples
P/E (TTM)-2.6
Forward P/E21.1
PEG Ratio0.06
Forward PEG0.06
P/B Ratio8.03
P/S Ratio0.00
EV/EBITDA-1.2
Per Share Data
EPS (TTM)$-1.66
Forward EPS (Est.)$0.21
Book Value / Share$0.53
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings Yield-38.78%
Forward Earnings Yield4.75%
Dividend Yield0.00%
Analyst Target$9.50 (+114.9%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -29.4 -0.28 -9.87 0.00 -
2017 -6.2 -0.02 -3.78 0.00 -
2018 85.4 -0.80 -6.18 0.00 -
2019 -73.2 3.71 16.33 0.00 -
2020 -10.7 0.09 5.21 0.00 -
2021 -5.3 0.00 5.98 0.00 -
2022 -0.7 0.07 4.65 0.00 -
2023 -0.2 0.00 -2.55 0.00 -
2024 -0.6 0.01 2.34 0.00 -
2025 -2.1 0.04 6.47 0.00 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-77.48 $0.00 $-11.39M -
2017 $-370.58 $0.00 $-54.49M -
2018 $26.70 $0.00 $5.92M -
2019 $21.44 $0.00 $4.75M -
2020 $-221.18 $0.00 $-35.32M -
2021 $-130.48 $0.00 $-40.71M -
2022 $-122.08 $0.00 $-39.53M -
2023 $-16.99 $0.00 $-23.87M -
2024 $-4.91 $0.00 $-29.02M -
2025 $-2.09 $0.00 $-34.17M -

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-1.48 $-1.66 – $-1.28 $850K $673.03K – $1.03M 3
2027 $-0.93 $-1.18 – $-0.67 $23.4M $18.53M – $28.27M 1
2028 $0.21 $0.15 – $0.27 $81.2M $64.29M – $98.11M 1
2029 $1.90 $1.39 – $2.41 $161.5M $127.88M – $195.12M 1
2030 $4.02 $2.93 – $5.11 $258.2M $204.44M – $311.96M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message